The field of clinical trials has encountered legal, technical, and regulatory challenges, both recent ones driven by initiatives to increase transparency, effectiveness, and equity and pre-existing ones accentuated by the rise of COVID-19. This conference will deconstruct complex issues to provide valuable insight on topics such as: clinical trial type, design, and labeling; clinical trial innovations, including machine learning and artificial intelligence; global expansion of clinical trials; clinical trial transparency, diversity, and patient engagement. It also will discuss practical tools, including statistics fundamentals, clinical trial funding, real world data and evidence usage, patient privacy, and due diligence to comply with increased clinical trial enforcement.

Internet Explorer and Microsoft Edge are not supported by the checkout process.

Please use Chrome, Firefox, or Safari.  If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.